Delivery Order SPE2DX15D3013-SPE2DX24FH4E4
Award Date
3/28/24
Potential Completion Date
3/29/24
Potential Value
$1.5K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract, valued at $7,191.55, is for the delivery of 4,564,261,053 tablets of the pharmaceutical product CONTRAVE ER 8-90 MG. The award does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and is also the holder of a $999,999,999.00 indefinite delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The award, valued at $19,115.24, is for the delivery of 4564104295 - CONTRAVE ER 8-90 MG TABLET 120S, a prescription pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with DLA, valued up to $999,999,999.00, to provide a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,637.26 award is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product, to support military treatment programs and facilities. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $19,447.34 order is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a specialty pharmaceutical product, with a performance period through March 27, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, with a ceiling value of $31,106.84, is for the provision of CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The contract has an ultimate completion date of March 26, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation. The delivery order is for the pharmaceutical product CONTRAVE ER 8-90 MG TABLET 120S, with a ceiling value of $8,787.25. The contract is a firm fixed price contract with an ultimate completion date of April 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to...
This $7,337.45 firm-fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The award is for the supply of CONTRAVE ER 8-90 MG TABLET 120S, a prescription medication, with a period of performance through July 29, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA...
The Defense Logistics Agency (DLA) awarded a $4,732.93 firm-fixed-price delivery order to AmerisourceBergen Drug Corp to provide 120 tablets of the drug CONTRAVE ER 8-90 MG TABLET. This delivery order was placed under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract has no set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. under the DLA Troop Support Medical Indefinite Delivery Contract, valued at up to $999,999,999 through December 2025. The $15,758.06 delivery order is for CONTRAVE ER 8-90 MG TABLET 120S, a pharmaceutical product. The delivery order has a firm fixed price and a completion date of August 30, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor and there is no...
This federal contract award, with ID SPE2DX15D3021|SPE2DX24F1KT0, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $3,802.65 firm fixed price delivery order is for the supply of 4564134995 CONTRAVE ER 8-90 MG TABLET 120S, a brand name pharmaceutical product. The award has an ultimate completion date of April 2, 2024. Amerisourcebergen Drug Corp serves as a...